牛叉诊股

[{"date":"2026.06.25","stock":"-1.88","trade":"-1.35","ind":"1.82"},{"date":"2026.06.24","stock":"-3.07","trade":"-0.89","ind":"1.24"},{"date":"2026.06.23","stock":"4.15","trade":"3.68","ind":"-3.17"},{"date":"2026.06.22","stock":"1.05","trade":"0.07","ind":"2.13"},{"date":"2026.06.18","stock":"-0.43","trade":"0.66","ind":"0.94"},{"date":"2026.06.17","stock":"-1.79","trade":"-1.16","ind":"1.31"},{"date":"2026.06.16","stock":"-1.01","trade":"-0.99","ind":"0.93"},{"date":"2026.06.15","stock":"-2.15","trade":"0.15","ind":"3.79"},{"date":"2026.06.12","stock":"0.50","trade":"2.07","ind":"0.75"},{"date":"2026.06.11","stock":"-1.79","trade":"-1.24","ind":"-0.68"},{"date":"2026.06.10","stock":"0.00","trade":"-0.14","ind":"-2.06"},{"date":"2026.06.09","stock":"0.66","trade":"0.45","ind":"3.02"},{"date":"2026.06.08","stock":"-3.33","trade":"-2.49","ind":"-3.22"},{"date":"2026.06.05","stock":"2.52","trade":"0.25","ind":"-2.21"},{"date":"2026.06.04","stock":"-2.46","trade":"-1.80","ind":"-0.27"},{"date":"2026.06.03","stock":"-2.02","trade":"-1.10","ind":"0.73"},{"date":"2026.06.02","stock":"-2.43","trade":"-2.06","ind":"1.63"},{"date":"2026.06.01","stock":"2.57","trade":"0.40","ind":"-1.51"},{"date":"2026.05.29","stock":"-1.23","trade":"0.36","ind":"-1.81"},{"date":"2026.05.28","stock":"-0.69","trade":"-0.71","ind":"0.80"},{"date":"2026.05.27","stock":"-2.96","trade":"-1.05","ind":"-0.88"}]

赛托生物,深证成指,化学制药指数

压力支撑

该股压力位为11.38元，支撑位为11.11元。

[{"text":"\u538b\u529b\u4f4d","value":"11.38","date":1782316800,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"11.11","date":1782316800,"color":"0x0b52a1"}]

多空趋势

空头行情中，并且有加速下跌的趋势。

macd kdj boll asi bias rsi wr vr

资金面诊股

诊断结果：4.7资金面打败了79%的股票主力控盘前10的股票

资金面得分最高的股票

主力控盘

据统计，近10日内主力筹码较分散，呈低度控盘状态。

没有控盘
轻度控盘
中度控盘
高度控盘

行业资金

化学制药行业，近5日资金总体无进出。

更新时间：06月25日 20:30

机构今日流向(万元)	-375.38	机构5日流向(万元)	521.18
机构10日流向(万元)	-1568.80	机构20日流向(万元)	-9197.81

机构持仓

2025-12-31 与 2025-06-30 相比，主力机构持仓量增加199.72万股，其中基金净增仓3家，主力净增仓15家，有一定的中长期投资价值。

截止2025-12-31，共48家主力机构（基金47家，一般法人1家），持仓量总计4621.92万股，占流通A股24.83%
其中，基金持仓与2025-06-30相比：
增仓：8家，增持 10.32万股
减仓：5家，减持 11.84万股
新出现在主力名单中：32家，持有228.96万股
从主力名单中消失：17家，原持有27.72万股

消息面诊股

诊断结果：5.9消息面打败了33%的股票今日有利好新闻的公司

近期该股消息面总体多空平衡，没有较强的利好或利空趋势。

消息面得分最高的股票

消息列表

一般消息	募资投向		2026-06-05
一般消息	股东大会	年度股东大会	2026-05-12
利好	分红转增	10派0.05元(含税)	2026-04-28
利好	业绩预告	预计减亏	2026-01-30
一般消息	重大事项	关联交易	2026-01-16
一般消息	重大事项	公司股东股份解押	2025-12-26
一般消息	高管变动	任职工董事	2025-09-12
利好	分红转增	10派0.1元(含税)	2025-08-26

一年消息统计

	所有消息	重大消息	非重大消息
利好	3条	0条	3条
利空	0条	0条	0条

行业面诊股

诊断结果：2.7行业面打败了37%的股票化学制药行业最新资金流向

近10日来该行业走势不明显，跑输大盘。

行业面得分最高的股票

行业走势

近10日来该行业走势不明显，跑输大盘。

[{"date":"2026.06.25","price":"1.82","value":"-1.35"},{"date":"2026.06.24","price":"1.24","value":"-0.89"},{"date":"2026.06.23","price":"-3.17","value":"3.68"},{"date":"2026.06.22","price":"2.13","value":"0.07"},{"date":"2026.06.18","price":"0.94","value":"0.66"},{"date":"2026.06.17","price":"1.31","value":"-1.16"},{"date":"2026.06.16","price":"0.93","value":"-0.99"},{"date":"2026.06.15","price":"3.79","value":"0.15"},{"date":"2026.06.12","price":"0.75","value":"2.07"},{"date":"2026.06.11","price":"-0.68","value":"-1.24"},{"date":"2026.06.10","price":"-2.06","value":"-0.14"},{"date":"2026.06.09","price":"3.02","value":"0.45"},{"date":"2026.06.08","price":"-3.22","value":"-2.49"},{"date":"2026.06.05","price":"-2.21","value":"0.25"},{"date":"2026.06.04","price":"-0.27","value":"-1.80"},{"date":"2026.06.03","price":"0.73","value":"-1.10"},{"date":"2026.06.02","price":"1.63","value":"-2.06"},{"date":"2026.06.01","price":"-1.51","value":"0.40"},{"date":"2026.05.29","price":"-1.81","value":"0.36"},{"date":"2026.05.28","price":"0.80","value":"-0.71"},{"date":"2026.05.27","price":"-0.88","value":"-1.05"}]

深证成指,化学制药行业

行业排名

排名	股票名称	1月涨跌幅	5日涨跌幅	评分
1	花园生物	78.37%	28.12%	5.7分
2	富祥股份	45.16%	23.49%	6.3分
3	灵康药业	35.84%	16.39%	5.8分
4	海欣股份	25.06%	33.79%	5.5分
5	贝达药业	24.15%	21.87%	6.2分
6	亨迪药业	18.32%	27.37%	5.0分
7	百利天恒	15.82%	18.70%	4.8分
8	通化金马	15.44%	8.57%	6.0分
9	科源制药	14.48%	-8.93%	5.4分
10	海南海药	12.78%	21.43%	5.2分
11	海思科	12.34%	19.46%	7.0分
12	-	12.07%	21.07%	分
13	海辰药业	11.17%	0.52%	5.3分
14	天宇股份	9.77%	8.97%	6.3分
15	纳微科技	9.77%	12.37%	5.9分
16	共同药业	8.40%	11.53%	4.9分
17	泽璟制药	6.67%	23.56%	5.7分
18	艾力斯	6.27%	14.50%	5.9分
19	中关村	5.77%	9.73%	5.5分
20	-	5.75%	6.36%	分
21	科伦药业	5.18%	5.36%	5.7分
22	-	3.77%	5.82%	分
23	海正药业	3.67%	8.29%	5.3分
24	华特达因	2.46%	2.46%	5.0分
25	千红制药	2.41%	10.21%	5.8分
26	东诚药业	2.22%	1.66%	5.3分
27	诚意药业	2.15%	2.53%	5.0分
28	圣诺生物	1.68%	7.61%	5.9分
29	百济神州	1.39%	14.64%	5.9分
30	丽珠集团	1.06%	-0.07%	5.1分
31	新华制药	0.67%	11.99%	4.8分
32	海翔药业	0.56%	4.67%	5.3分
33	兴齐眼药	0.52%	9.75%	4.9分
34	新和成	0.47%	5.26%	4.6分
35	吉贝尔	0.16%	3.38%	4.6分
36	赛分科技	0.10%	-2.20%	5.2分
37	恒瑞医药	-0.66%	6.49%	5.9分
38	-	-0.66%	-1.81%	分
39	威尔药业	-0.99%	1.76%	4.3分
40	华北制药	-1.36%	-0.23%	4.4分
41	-	-1.41%	-1.91%	分
42	民生健康	-1.49%	3.54%	4.8分
43	普洛药业	-1.97%	1.04%	5.9分
44	仙琚制药	-2.07%	-3.01%	4.4分
45	司太立	-2.17%	10.21%	5.4分
46	复旦张江	-2.17%	6.80%	4.9分
47	健康元	-2.18%	0.72%	4.6分
48	山河药辅	-2.24%	0.00%	4.3分
49	国邦医药	-2.34%	-2.02%	4.2分
50	金陵药业	-2.45%	-1.65%	5.4分
51	力生制药	-2.45%	1.20%	5.3分
52	前沿生物	-2.48%	16.86%	5.9分
53	亿帆医药	-2.70%	-0.82%	5.0分
54	华东医药	-3.19%	0.69%	5.2分
55	同和药业	-3.20%	2.15%	4.9分
56	-	-3.64%	-1.04%	分
57	-	-3.65%	-0.69%	分
58	ST能特	-3.67%	-4.11%	4.0分
59	小方制药	-3.69%	1.22%	4.3分
60	键凯科技	-3.91%	7.03%	5.8分
61	奥锐特	-3.99%	-2.06%	5.2分
62	金石亚药	-4.11%	7.05%	5.1分
63	东北制药	-4.18%	0.46%	4.5分
64	石药创新	-4.25%	6.26%	5.3分
65	京新药业	-4.35%	4.07%	5.4分
66	华润双鹤	-4.45%	-3.30%	4.2分
67	华邦健康	-4.46%	-3.10%	4.1分
68	复星医药	-4.89%	2.78%	4.6分
69	北大医药	-4.92%	-6.69%	4.4分
70	哈三联	-5.23%	-4.38%	4.3分
71	ST惠程	-5.26%	-5.01%	4.8分
72	辰欣药业	-5.26%	-0.15%	3.9分
73	立方制药	-5.35%	1.79%	5.0分
74	ST人福	-5.35%	-0.48%	4.0分
75	金城医药	-5.63%	-0.71%	5.2分
76	-	-5.86%	2.18%	分
77	信立泰	-6.47%	3.95%	5.5分
78	丰原药业	-6.61%	-0.57%	5.0分
79	北陆药业	-6.74%	2.65%	4.7分
80	华海药业	-7.25%	2.82%	5.5分
81	凯因科技	-7.34%	0.00%	4.0分
82	海普瑞	-7.38%	1.35%	5.3分
83	华仁药业	-7.58%	-0.39%	4.9分
84	-	-7.62%	-1.58%	分
85	罗欣药业	-7.73%	-1.01%	4.9分
86	双鹭药业	-7.88%	6.96%	4.4分
87	哈药股份	-7.95%	-1.95%	4.5分
88	盟科药业	-8.00%	-0.46%	4.2分
89	恩华药业	-8.03%	0.96%	4.8分
90	微芯生物	-8.05%	1.28%	4.7分
91	卫信康	-8.15%	-1.74%	3.9分
92	亚太药业	-8.17%	0.98%	3.6分
93	福安药业	-8.71%	-1.98%	5.0分
94	川宁生物	-8.80%	-1.92%	4.1分
95	新天地	-8.82%	1.45%	4.2分
96	国药现代	-8.91%	-3.46%	3.9分
97	津药药业	-8.93%	1.96%	4.1分
98	ST诺泰	-9.09%	-1.58%	4.2分
99	浙江医药	-9.22%	-1.27%	4.7分
100	神奇制药	-9.22%	-2.32%	5.1分
101	康芝药业	-9.42%	-1.97%	3.7分
102	永安药业	-9.58%	-1.58%	4.6分
103	海森药业	-9.75%	-4.94%	4.1分
104	宏源药业	-9.75%	1.69%	5.3分
105	润都股份	-9.86%	-1.12%	4.7分
106	天新药业	-9.93%	-4.39%	4.2分
107	德展健康	-9.94%	-0.33%	3.9分
108	翰宇药业	-10.68%	-0.63%	5.9分
109	健友股份	-10.97%	-0.28%	4.4分
110	鲁抗医药	-11.01%	1.14%	4.5分
111	福元医药	-11.39%	-3.77%	4.6分
112	宣泰医药	-11.40%	0.13%	3.8分
113	拓新药业	-11.45%	-3.40%	3.4分
114	溢多利	-11.67%	0.35%	4.5分
115	益方生物	-12.14%	3.05%	5.0分
116	舒泰神	-12.21%	4.43%	4.3分
117	赛托生物	-12.44%	-0.35%	4.4分
118	富士莱	-12.46%	-2.37%	4.4分
119	向日葵	-12.68%	-3.90%	3.5分
120	泰恩康	-12.88%	-5.06%	4.0分
121	誉衡药业	-13.13%	0.39%	5.2分
122	汇宇制药	-13.17%	-2.11%	4.4分
123	易明医药	-13.27%	-4.60%	5.6分
124	华纳药厂	-13.28%	-3.40%	3.9分
125	西点药业	-13.30%	-0.48%	4.5分
126	本立科技	-13.50%	-2.83%	4.2分
127	汉商集团	-13.77%	-2.98%	4.0分
128	必贝特	-13.80%	5.47%	5.9分
129	联环药业	-14.32%	-4.86%	4.1分
130	尔康制药	-14.43%	-1.17%	4.2分
131	海创药业	-14.57%	1.54%	3.9分
132	首药控股	-14.74%	6.68%	4.8分
133	ST天圣	-15.33%	-7.75%	4.5分
134	九典制药	-15.37%	-3.32%	4.1分
135	苑东生物	-15.45%	-1.89%	4.0分
136	一品红	-16.05%	6.41%	5.9分
137	莎普爱思	-16.41%	-3.74%	4.3分
138	广济药业	-16.55%	-3.52%	4.2分
139	多瑞医药	-16.61%	-5.56%	4.2分
140	亚虹医药	-16.94%	-4.83%	3.7分
141	东亚药业	-17.43%	-6.16%	4.8分
142	奥赛康	-17.76%	2.94%	5.9分
143	ST复华	-18.46%	-11.42%	3.3分
144	奥翔药业	-18.99%	-3.37%	4.3分
145	冀衡医药	-19.81%	-5.82%	3.7分
146	莱美药业	-20.93%	-8.05%	3.9分
147	广生堂	-21.46%	4.33%	5.3分
148	中哲精化	-21.75%	-4.80%	4.8分
149	景峰医药	-22.62%	-6.34%	4.1分
150	昂利康	-24.50%	-0.11%	5.0分
151	美诺华	-26.35%	-9.47%	3.7分
152	仟源医药	-27.15%	-7.00%	4.3分
153	*ST赛隆	-28.14%	-22.65%	4.2分
154	迪哲医药	-28.24%	6.69%	5.6分
155	悦康药业	-29.60%	-1.43%	4.4分
156	博瑞医药	-33.34%	-9.68%	4.5分
157	ST南新	-33.37%	-7.33%	3.2分
158	上海谊众	-33.65%	3.87%	4.5分
159	常山药业	-35.69%	0.64%	4.9分

<上一页 1 2 3 4 5...27 下一页>

行业评级

研究机构	评级日期	最新评级	上次评级
暂无相关评级

基本面诊股

诊断结果：5.9基本面打败了50%的股票连续3年业绩增长30%的公司

该公司运营状况尚可，暂时未获得多数机构的显著认同，后续可继续关注。

个股深一度

潜在高分红能力：弱（80分）

基本面得分最高的股票

[ 截止日期：2026-03-31 ]公司经营

盈利能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 116/218 ， 136/218。

[{"date":"2026-03-31","value":"0.20","vol":"0.43"},{"date":"2025-12-31","value":"-4.06","vol":"-2.03"},{"date":"2025-09-30","value":"-3.84","vol":"1.53"},{"date":"2025-06-30","value":"-2.91","vol":"1.24"},{"date":"2025-03-31","value":"-1.51","vol":"-0.13"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
净资产收益率(%)	0.20	-4.06	-3.84	-2.91	-1.51
行业(%)	0.43	-2.03	1.53	1.24	-0.13

该指标值越高，盈利能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"22.08","vol":"50.72"},{"date":"2025-12-31","value":"15.00","vol":"49.72"},{"date":"2025-09-30","value":"12.53","vol":"49.60"},{"date":"2025-06-30","value":"12.01","vol":"49.57"},{"date":"2025-03-31","value":"8.94","vol":"49.06"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
销售毛利率(%)	22.08	15.00	12.53	12.01	8.94
行业(%)	50.72	49.72	49.60	49.57	49.06

该指标值越高，盈利能力越强，行业排名越靠前。

成长能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 27/218 ， 22/218。

[{"date":"2026-03-31","value":"26.24","vol":"25.51"},{"date":"2025-12-31","value":"4.77","vol":"38.97"},{"date":"2025-09-30","value":"-2.07","vol":"141.63"},{"date":"2025-06-30","value":"-10.39","vol":"78.56"},{"date":"2025-03-31","value":"6.32","vol":"0.01"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
营业收入同比增长率(%)	26.24	4.77	-2.07	-10.39	6.32
行业(%)	25.51	38.97	141.63	78.56	0.01

该指标值越高，成长能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"113.15","vol":"47.13"},{"date":"2025-12-31","value":"17.60","vol":"-26.11"},{"date":"2025-09-30","value":"-570.46","vol":"-2.93"},{"date":"2025-06-30","value":"-498.80","vol":"59.61"},{"date":"2025-03-31","value":"-995.83","vol":"-10.40"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
净利润同比增长率(%)	113.15	17.60	-570.46	-498.80	-995.83
行业(%)	47.13	-26.11	-2.93	59.61	-10.40

该指标值越高，成长能力越强，行业排名越靠前。

营运能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 66/218 ， 66/218。

[{"date":"2026-03-31","value":"0.11","vol":"0.10"},{"date":"2025-12-31","value":"0.34","vol":"0.41"},{"date":"2025-09-30","value":"0.25","vol":"0.31"},{"date":"2025-06-30","value":"0.17","vol":"0.21"},{"date":"2025-03-31","value":"0.09","vol":"0.10"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
总资产周转率(次)	0.11	0.34	0.25	0.17	0.09
行业(次)	0.10	0.41	0.31	0.21	0.10

该指标值越高，营运能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"0.59","vol":"0.65"},{"date":"2025-12-31","value":"1.54","vol":"2.58"},{"date":"2025-09-30","value":"1.15","vol":"1.93"},{"date":"2025-06-30","value":"0.77","vol":"1.29"},{"date":"2025-03-31","value":"0.40","vol":"0.66"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
存货增长率(次)	0.59	1.54	1.15	0.77	0.40
行业(次)	0.65	2.58	1.93	1.29	0.66

该指标值越高，营运能力越强，行业排名越靠前。

现金流能力：数据暂时不全，请后续关注

[{"date":"2026-03-31","value":"9.37","vol":"-2.81"},{"date":"2025-12-31","value":"30.16","vol":"16.49"},{"date":"2025-09-30","value":"6.27","vol":"4.26"},{"date":"2025-06-30","value":"29.43","vol":"2.95"},{"date":"2025-03-31","value":"-3.95","vol":"-26.33"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
现金流量净额/营业收入	9.37	30.16	6.27	29.43	-3.95
行业	-2.81	16.49	4.26	2.95	-26.33

该指标值越高，现金流能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"0.47","vol":"1.60"},{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"0.29","vol":"1.71"},{"date":"2025-03-31","value":"","vol":"0.00"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
资本支出／折旧和摊销	-	0.47	-	0.29	-
行业	0.00	1.60	0.00	1.71	0.00

该指标值越低，现金流能力越强，行业排名越靠前。

短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 54/218 ， 14/218。

[{"date":"2026-03-31","value":"1.27","vol":"3.57"},{"date":"2025-12-31","value":"1.28","vol":"3.31"},{"date":"2025-09-30","value":"1.21","vol":"3.48"},{"date":"2025-06-30","value":"1.23","vol":"3.66"},{"date":"2025-03-31","value":"1.25","vol":"3.57"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
流动比率	1.27	1.28	1.21	1.23	1.25
行业	3.57	3.31	3.48	3.66	3.57

该指标值越接近2，短期偿债能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"0.84","vol":"2.93"},{"date":"2025-12-31","value":"0.78","vol":"2.69"},{"date":"2025-09-30","value":"0.69","vol":"2.73"},{"date":"2025-06-30","value":"0.69","vol":"2.88"},{"date":"2025-03-31","value":"0.65","vol":"2.80"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
速动比率	0.84	0.78	0.69	0.69	0.65
行业	2.93	2.69	2.73	2.88	2.80

该指标值越接近1，短期偿债能力越强，行业排名越靠前。

长期偿债能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 40/218 ， 57/218。

[{"date":"2026-03-31","value":"38.56","vol":"33.54"},{"date":"2025-12-31","value":"39.21","vol":"34.70"},{"date":"2025-09-30","value":"37.15","vol":"34.06"},{"date":"2025-06-30","value":"37.66","vol":"34.12"},{"date":"2025-03-31","value":"36.92","vol":"34.09"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
资产负债率(%)	38.56	39.21	37.15	37.66	36.92
行业(%)	33.54	34.70	34.06	34.12	34.09

该指标值越接近50%，长期偿债能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"0.64","vol":"9.77"},{"date":"2025-12-31","value":"0.66","vol":"1.76"},{"date":"2025-09-30","value":"0.60","vol":"1.19"},{"date":"2025-06-30","value":"0.62","vol":"0.87"},{"date":"2025-03-31","value":"0.60","vol":"1.44"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
产权比率 (%)	0.64	0.66	0.60	0.62	0.60
行业(%)	9.77	1.76	1.19	0.87	1.44

该指标值越高，长期偿债能力越强，行业排名越靠前。

机构评级

最近60个交易日，机构对该股票关注较少，无任何评级。

研究机构	评级日期	最新评级	上次评级
暂无数据

机构预测

暂时还没有机构预测该股2026年的收益，请投资者后续关注。

[{"date":"2022","yellowRectValue":"0.42","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"0.46","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"-0.89","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"-0.73","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]

[赛托生物]

技术面诊股
资金面诊股
消息面诊股
行业面诊股
基本面诊股

【数据基于历史，不代表未来趋势；诊股基于模型与测试，需要投资者根据不同行情合理运用、独立判断、控制风险】

证券咨询服务提供：浙江同花顺云软件有限公司 [编号：zx0050]